首页

类风湿关节炎的联合医治计划有哪些 不同医治计划对类风湿关节炎的作用调查

点击:0时间:2025-04-12 17:52:51

林伟耿+林秋强+陈韧

[摘要]意图 讨论不同医治计划对类风湿关节炎(RA)的作用。办法 挑选2014年6月~2015年8月首诊于澄海人民医院风湿科门诊的250例RA患者作为研讨目标,按就诊序号随机将其分为甲氨蝶呤(MTX)组、来氟米特(LEF)组、MTX+LEF组、MTX+雷公藤多苷组、MTX+白芍总苷组,各50例,调查五组患者的效果及不良反应。成果 医治后2周,五组临床及实验室效果附近,差异无统计学含义(P>0.05);医治后4、12及24周,MTX+LEF组、LEF组、MTX+雷公藤多苷组、MTX+白芍总苷组临床及实验室效果均优于MTX组,差异有统计学含义(P<0.05)。MTX+LEF组不良反应发生率(20.00%)显着低于MTX组(38.00%),差异有统计学含义(χ2=3.93,P<0.05)。定论 MTX+LEF医治RA效果切当、不良反应较少,应在临床要点引荐使用。

[关键词]类风湿关节炎;不同计划;效果;安全性

[中图分类号] R684.3 [文献标识码] A [文章编号] 1674-4721(2016)06(a)-0004-05

[Abstract]Objective To explore the effects of different treatment program in rheumatoid arthritis(RA).Methods 250 patients with RA who got first diagnosis in department of rheumatism of Chenghai people′s hospital from June 2014 to August 2015 were selected as study objects.250 RA patients were randomly divided into methotrexate(MTX) group,leflunomide(LEF) group,MTX+LEF group,MTX+tripterygium glycosides group and MTX+total glucoside of paeony group according to the admission order,and each group was 50 cases.The effects adverse and curative effect among five groups were observed.Results Two weeks after followed up treatment,the clinical and laboratory efficacy of the five groups were similar,and the difference had no statistical significance(P>0.05);Four,twelve and twenty-four weeks after followed up,the clinical and laboratory efficacy in MTX+LEF group,LEF group,MTX+tripterygium glycosides group and MTX+total glucoside of paeony group was better than that of MTX group respectively,and the difference was statistical significance(P<0.05).The adverse effects in MTX+LEF group was 20.00%,obvious lower than that was 38.00% in MTX group,and the difference was statistical significance(χ2=3.93,P<0.05).Conclusion The effects of MTX+LEF in treating RA is exact,and with less adverse effects.It should be major recommended use in clinic.

[Key words]Rheumatoid arthritis;Different program;Curative effect;Safety

类风湿关节炎(rheumatoid arthritis,RA)是一组以关节滑膜炎症为主要特征的缓慢、全身性本身免疫系统疾病,跟着病况继续发展,可导致关节痛苦、强直或变形病变,影响患者肢体功用,下降患者日子质量[1]。很多临床研讨[1-3]证明,前期、活跃有效地操控病况,是推迟骨损坏的重要因素,对下降致残率、改进患者日子质量具有重要含义。本文分组研讨我院风湿科门诊的250例活动期RA患者,比较不同医治计划在缓解病况、保持病况安稳、操控复发及药物不良反应等方面的好坏,以期找到医治RA的最优计划。

1材料与办法

1.1一般材料

挑选2014年6月~2015年8月首诊于澄海人民医院风湿科门诊的250例RA患者作为研讨目标,确诊均契合1987年美国风湿病学会修订的RA确诊分类规范[4],且一切患者RA病况均处于活动期。当选患者均存在不同程度的关节痛苦、肿胀、晨僵、活动妨碍等体现。按就诊序号随机将250例RA患者分为甲氨蝶呤(MTX)组、来氟米特(LEF)组、MTX+LEF组、MTX+雷公藤多苷组、MTX+白芍总苷组,每组50例。五组患者的性别、年纪、病程等一般材料比较,差异无统计学含义(P>0.05)(表1),具可比性。本研讨经过医院道德委员会认证同意,一切患者均自愿参加研讨。

相关资讯
最新新闻
关闭